Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.

By G. Raghu, Shih-Yin Chen, W. Yeh, B. Maroni, Qian Li, Yuan-chi Lee, H. Collard. The Lancet Respiratory Medicine, 2014

598 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/37e2aedcc19b41fc9ff1a3a6fcc687c7e3a4b8ed

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. H. Collard
2. G. Raghu

Citations in the corpus

• Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study (2019, background): “8 years in newly-diagnosed adults over 60 years of age [4].”
• Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline (2018, background): “The incidence of IPF increases with older age, with presentation typically consisting of insidious onset of dyspnea in the sixth and seventh decades (8, 9).”